MAPKAPK5 and posterior cortical atrophy: Clinical Implications for PCa Patients Selection: It appears that employing an approach to inhibit TLK1-MK5 in localized prostate cancer to prevent metastasis presents a challenging opportunity for clinical adoption, as the timing and duration of such therapy do not seem to provide a clear clinical window.